Many congratulations to Prof Keith Matthews newly elected to fellowship of the Academy of Medical Sciences
Prof Keith Matthews in the School of Biological Sciences is among 48 of the UK’s world leading researchers elected to join the prestigious Fellowship of the Academy of Medical Sciences.
Fellows are elected for their outstanding contributions to biomedical and health science, leading research discoveries, and translating developments into benefits for patients and the wider society.
Keith’s studies on the lifecycle of Trypanosome parasites have led to significant advances in understanding disease severity and spread in Sub-Saharan Africa.
“I am honoured to be elected a Fellow of the Academy of Medical Sciences. Infectious Disease research is enormously strong at the University of Edinburgh and my laboratory has benefited immensely from this diverse, collegiate and interactive environment.”
African Trypanosome parasites are spread by the Tsetse fly and cause ‘sleeping sickness’ in humans and the devastating disease ‘nagana’ in cattle and other livestock, causing major agricultural losses.
Keith's research is unravelling the processes that allow parasites to change into a ‘stumpy’ form, which maximises their ability to spread to tsetse flies. Recent work by his group has also revealed that disease spread may be boosted by social interactions between parasites and competition between species could influence disease severity.
Tackling the disease is difficult as there are no vaccines for cattle and existing drugs are old and have dangerous side effects. Identifying vulnerable points in the parasite’s lifecycle could lead to new ways to limit the spread of the disease or its severity through drug therapy.
Professor Matthews was 2008 recipient of the C. A. Wright medal from the British Society for Parasitology and elected Fellow of the Royal Society of Edinburgh in 2014.
In 2015, he was the Sanofi-Pasteur International laureate for his outstanding contributions to the field of tropical medicine and neglected diseases. The Academy of Medical Sciences elected 48 new Fellows, including two from the University of Edinburgh.
Profs Giles Hardingham and Rick Maizels elected fellows
In addition to Keith, Prof Giles Hardingham, City of Edinburgh Professor of Pharmacology at the University of Edinburgh and Professor Rick Maizels, formerly Director of Edinburgh Infectious Diseases, now at the University of Glasgow, were elected to Fellowship.
All of the 48 new Fellows have been elected for their outstanding contributions to biomedical and health science, leading research discoveries, and translating developments into benefits for patients and the wider society.
“The Academy simply could not tackle major health and policy challenges without our dynamic and diligent brain trust of Fellows. I extend my warmest congratulations to all who are joining us this year, each of whom has earnt this prestige by advancing their own field of biomedical science.
Later this year the Academy will celebrate 20 years of supporting the translation of biomedical and health research into benefits for society. As we celebrate this special anniversary we stand at a crossroads of both enormous health challenges and great opportunity for medical sciences. So I am delighted to see the remarkable breadth and depth of the expertise within our 48 new Fellows. We look forward to these experts joining us in addressing the health challenges we face head on and exploiting opportunities to improve health in the UK and internationally.”
The new Fellows will be formally admitted to the Academy at a ceremony on 27 June 2018.
All new Fellows elected in 2018
Dr David Adams, Senior Group Leader, Wellcome Trust Sanger Institute
Professor Louise Arseneault, Professor of Developmental Psychology, King's College London
Professor Eleanor Barnes, Professor of Hepatology and Experimental Medicine, University of Oxford of Developmental Psychopathology, University of Cambridge
Professor David Beeson, Professor in Molecular Neuroscience, University of Oxford
Professor Ashley Blom, Head of the Department of Translational Health Sciences, University of Bristol
Professor Elizabeth Corbett, Professor of Tropical Epidemiology, London School of Hygiene and Tropical Medicine
Professor Augusto Cuello, Charles E Frosst/Merck Chair in Pharmacology, McGill University
Professor Melanie Davies CBE, Professor of Diabetes Medicine, University of Leicester
Professor Panagiotis Deloukas, Professor of Cardiovascular Genomics, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Professor Derk-Jan Dijk, Professor of Sleep and Physiology, University of Surrey
Professor John Edmunds OBE, Dean, Faculty of Epidemiology and Population Health, and Professor of Infectious Disease Modelling, London School of Hygiene and Tropical Medicine
Dr Susan Galbraith, Senior Vice-President & Head Oncology Innovative Medicines, AstraZeneca
Professor Simon Griffin, Professor of General Practice, University of Cambridge
Professor Ian Hall, Boots Chair in Therapeutics & Honorary Consultant Physician NUH NHS Trust, Director Centre for Bimolecular Sciences, University of Nottingham
Professor Giles Hardingham FRSE, City of Edinburgh Professor of Pharmacology; Associate Director, UK Dementia Research Institute, University of Edinburgh
Professor Elaine Holmes, Professor of Chemical Biology, Head of Computational and Systems Medicine, Imperial College London
Professor James Huntington, Professor of Molecular Haemostasis, University of Cambridge
Professor Peter Hutchinson, Professor of Neurosurgery, University of Cambridge
Professor Susan Jebb OBE, Professor of Diet and Population Health, University of Oxford
Professor Frank Kelly, Professor of Environmental Health, King's College London
Professor Mika Kivimaki, Professor, Epidemiology and Public Health, University College London
Dr James Larkin, Consultant in Medical Oncology and Honorary Senior Lecturer, Royal Marsden Hospital
Professor Timothy Leighton FRS FREng, Professor of Ultrasonics and Underwater Acoustics, University of Southampton
Professor Giovanna Lombardi, Professor of Immunology, King's College London
Professor Robert MacLaren, Professor of Ophthalmology, University of Oxford
Professor Margaret Maclean MBE FRSE, Professor of Pulmonary Pharmacology, University of Glasgow
Professor Richard Maizels FRSE, Professor of Parasitology, University of Glasgow
Professor Jonathan Mant, Professor of Primary Care Research, University of Cambridge
Professor Keith Matthews FRSE, Professor of Parasite Biology, University of Edinburgh
Professor Christopher Nutting, Consultant and Professor in Clinical Oncology, Royal Marsden Hospital
Professor Ruth Plummer, Professor of Experimental Cancer Medicine, Newcastle University
Professor Jordan Raff, César Milstein Professor of Cancer Cell Biology, University of Oxford
Professor Lalita Ramakrishnan, Professor of Medicine and Infectious Disease, University of Cambridge
Professor David Rowitch, Professor of Paediatrics & Head of the Department of Paediatrics, University of Cambridge
Dr William Schafer, Programme Leader, MRC Laboratory of Molecular Biology
Professor Nicole Soranzo, Head of Human Complex Traits Group, Wellcome Trust Sanger Institute
Professor Robert Steele, Professor of Surgery and Head of Cancer Research Division, University of Dundee
Professor Jesper Svejstrup FRS, Senior Group Leader, The Francis Crick Institute
Professor Guy Thwaites, Professor of Infectious Diseases, University of Oxford and Director, Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Research Program in Vietnam
Professor Martin Tobin, Professor of Genetic Epidemiology and Public Health, University of Leicester
Dr Sharon Tooze, Senior Scientist, The Francis Crick Institute; Honorary Professor, University College London
Professor Jørgen Vestbo, Professor Respiratory Medicine, University of Manchester
Dr Pauline Williams, Senior Vice President and Head of Global Health R&D, GlaxoSmithKline
Professor Catherine Williamson, Professor of Women’s Health, King's College London
Professor Paula Williamson, Professor of Medical Statistics, University of Liverpool
Dr Anthony Wood, Senior Vice President and Head of Platform Technologies and Sciences, GlaxoSmithKline
Professor Mark Woodward, Professor of Epidemiology and Statistics, University of Oxford